secwatch.observer — SEC 8-K summary
======================================

Issuer:     CNBX Pharmaceuticals Inc. (CNBX)
CIK:        0001343009
Form:       8-K
Filed at:   2022-02-17T23:59:59+00:00
Accession:  0001683168-22-001084
Event type: debt
Sentiment:  negative
Materiality: 0.70
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cannabics Pharmaceuticals enters forbearance on $1.375M defaulted note, forbearance until March 7, 2022
--------------------------------------------------------------------------------

- Company defaulted on $1,375,000 Senior Secured Convertible Promissory Note due December 21, 2021.
- Investor agrees to forbear from enforcing remedies through March 7, 2022, subject to earlier termination.
- Investor waives certain defaults and registration rights during the forbearance period.
- Company acknowledges no defenses, offsets, or counterclaims regarding the note and its obligations.
- Forbearance terminates automatically on March 7, 2022 or upon a Forbearance Default (5 business days cure).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1343009/000168316822001084/0001683168-22-001084-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1343009/000168316822001084/cannabics_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-22-001084

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer